Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey

Objectives This study aimed to assess the role of community pharmacists in managing abnormal uterine bleeding (AUB) in women on anticoagulant therapy, particularly in the context of a physician shortage in France, which exacerbates the pharmacist's role. Recognizing these bleedings, which impai...

Full description

Saved in:
Bibliographic Details
Main Authors: Sibylle Frerebeau PharmD, Benjamin Planquette MD, PhD, Gabrielle Sarlon MD, PhD, Nicolas Gendron PharmD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2025-06-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296251350078
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849716028606513152
author Sibylle Frerebeau PharmD
Benjamin Planquette MD, PhD
Gabrielle Sarlon MD, PhD
Nicolas Gendron PharmD, PhD
author_facet Sibylle Frerebeau PharmD
Benjamin Planquette MD, PhD
Gabrielle Sarlon MD, PhD
Nicolas Gendron PharmD, PhD
author_sort Sibylle Frerebeau PharmD
collection DOAJ
description Objectives This study aimed to assess the role of community pharmacists in managing abnormal uterine bleeding (AUB) in women on anticoagulant therapy, particularly in the context of a physician shortage in France, which exacerbates the pharmacist's role. Recognizing these bleedings, which impair the quality of life for women, is an essential role of pharmacists and could be crucial in preventing the risk of discontinuing anticoagulant treatment. Methods We conducted an anonymous survey from December 2023 to January 2024 among pharmacists in France to explore their experiences with patients on anticoagulants who presented at pharmacies with questions about AUB. Results Of the 115 respondents, only 9 (7.8%) pharmacists had been approached by patients with questions about AUB while on anticoagulants. These pharmacists reported a majority of cases in women of reproductive age, the drug the most frequently cited was rivaroxaban. No significant demographic differences were observed between the pharmacists who had faced these questions and those who had not. Additionally, 99 (86.1%) pharmacists considered that they did not have enough skills to adequately advise female patients about abnormal uterine/genital bleeding under anticoagulant therapy. Conclusion Our study showed that community pharmacists are not the primary healthcare contact for patients with AUB under anticoagulant therapy. Despite this, the low frequency of pharmacist-patient interactions regarding AUB suggests potential under-diagnosis and under-communication of adverse effects that negatively impact the quality of life of women on anticoagulants.
format Article
id doaj-art-b3c9e30aaab34d2d95ce42600669f712
institution DOAJ
issn 1938-2723
language English
publishDate 2025-06-01
publisher SAGE Publishing
record_format Article
series Clinical and Applied Thrombosis/Hemostasis
spelling doaj-art-b3c9e30aaab34d2d95ce42600669f7122025-08-20T03:13:08ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232025-06-013110.1177/10760296251350078Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French SurveySibylle Frerebeau PharmD0Benjamin Planquette MD, PhD1Gabrielle Sarlon MD, PhD2Nicolas Gendron PharmD, PhD3 Hematology Department, Hôpital européen Georges Pompidou, Assistance Publique Hôpitaux de Paris-Centre Université Paris Cité (APHP-CUP), Paris, France Investigation Network on Venous Thrombo-Embolism (INNOVTE)–French Clinical Research Infrastructure Network, SaintÉtienne, France Service de Médecine vasculaire, Hôpital de la Timone, Assistance publique–Hôpitaux de Marseille (AP–HM), Aix-Marseille université (AMU), Marseille, France Paris Cité University, INSERM, Paris Cardiovascular Research Centre, Team Endotheliopathy and Hemostasis disorders, Paris, FranceObjectives This study aimed to assess the role of community pharmacists in managing abnormal uterine bleeding (AUB) in women on anticoagulant therapy, particularly in the context of a physician shortage in France, which exacerbates the pharmacist's role. Recognizing these bleedings, which impair the quality of life for women, is an essential role of pharmacists and could be crucial in preventing the risk of discontinuing anticoagulant treatment. Methods We conducted an anonymous survey from December 2023 to January 2024 among pharmacists in France to explore their experiences with patients on anticoagulants who presented at pharmacies with questions about AUB. Results Of the 115 respondents, only 9 (7.8%) pharmacists had been approached by patients with questions about AUB while on anticoagulants. These pharmacists reported a majority of cases in women of reproductive age, the drug the most frequently cited was rivaroxaban. No significant demographic differences were observed between the pharmacists who had faced these questions and those who had not. Additionally, 99 (86.1%) pharmacists considered that they did not have enough skills to adequately advise female patients about abnormal uterine/genital bleeding under anticoagulant therapy. Conclusion Our study showed that community pharmacists are not the primary healthcare contact for patients with AUB under anticoagulant therapy. Despite this, the low frequency of pharmacist-patient interactions regarding AUB suggests potential under-diagnosis and under-communication of adverse effects that negatively impact the quality of life of women on anticoagulants.https://doi.org/10.1177/10760296251350078
spellingShingle Sibylle Frerebeau PharmD
Benjamin Planquette MD, PhD
Gabrielle Sarlon MD, PhD
Nicolas Gendron PharmD, PhD
Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey
Clinical and Applied Thrombosis/Hemostasis
title Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey
title_full Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey
title_fullStr Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey
title_full_unstemmed Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey
title_short Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey
title_sort pharmacists knowledge of abnormal uterine bleeding in women on anticoagulant therapy a french survey
url https://doi.org/10.1177/10760296251350078
work_keys_str_mv AT sibyllefrerebeaupharmd pharmacistsknowledgeofabnormaluterinebleedinginwomenonanticoagulanttherapyafrenchsurvey
AT benjaminplanquettemdphd pharmacistsknowledgeofabnormaluterinebleedinginwomenonanticoagulanttherapyafrenchsurvey
AT gabriellesarlonmdphd pharmacistsknowledgeofabnormaluterinebleedinginwomenonanticoagulanttherapyafrenchsurvey
AT nicolasgendronpharmdphd pharmacistsknowledgeofabnormaluterinebleedinginwomenonanticoagulanttherapyafrenchsurvey